Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Asthma

Free Subscription Articles published in Respir Med Retrieve available abstracts of 176 articles: HTML format

Single Articles

April 2026
1. DUPONT L, Pilette C, Deschampheleire M, Eger K, et al
   Rapid & sustained benefit of benralizumab in severe eosinophilic asthma: the BE-REAL study.
   Respir Med. 2026 Apr 25:108854. doi: 10.1016/j.rmed.2026.108854.
   PubMed     Abstract available
   
   
   
2. BELLVER-ASPERILLA C, Romero Ortiz A, Cabrerizo-Carreno H, Orozco Echeverria S, et al
   Dupilumab-induced eosinophilia in severe asthma: 2-year follow-up real-life evidence from biologic-naive and previously treated patients.
   Respir Med. 2026;257:108855.
   PubMed     Abstract available
   
   
   
3. NAJDA M, Yan Y, van Bemmel L, Franssen FME, et al
   Breathing and Speech Patterns for Predictive Modelling of Exacerbations of Asthma and COPD.
   Respir Med. 2026 Apr 21:108829. doi: 10.1016/j.rmed.2026.108829.
   PubMed     Abstract available
   
   
   
4. DOMINGUEZ-ORTEGA J, Almonacid C, Alvarez-Gutierrez FJ, Cisneros C, et al
   Temporal Trends in Baseline Severity and 12-Month Response to Mepolizumab in Severe Asthma: The TYREX Multicentre Real-World Study in Spain (2017-2024).
   Respir Med. 2026 Apr 21:108849. doi: 10.1016/j.rmed.2026.108849.
   PubMed     Abstract available
   
   
   
5. WU WW, Wang XL
   Treatable traits of asthma in adults: a population-based study based on the National Health and Nutrition Examination Survey.
   Respir Med. 2026;257:108850.
   PubMed     Abstract available
   
   
   
6. KHANAM UA, Katselis GS, Gao Z, Rennie D, et al
   Investigation of the Use of Urinary Proteomics in the Prediction of Childhood Asthma.
   Respir Med. 2026 Apr 17:108828. doi: 10.1016/j.rmed.2026.108828.
   PubMed     Abstract available
   
   
   
7. GUO Y, Wang G, Zhou C, Gan Z, et al
   Regional Differences in Sensitization Patterns Among Children with Allergic Asthma in China: A Latent Class Analysis and Age-Related Characteristics.
   Respir Med. 2026 Apr 17:108845. doi: 10.1016/j.rmed.2026.108845.
   PubMed     Abstract available
   
   
   
8. HUANG H, Liang H, Wang J, Gong Z, et al
   Type 2 biomarkers outperform asthma-COPD overlap definitions in predicting clinical outcomes in COPD patients initiating triple therapy: A prospective cohort study.
   Respir Med. 2026;257:108825.
   PubMed     Abstract available
   
   
   
9. VILANOVA-PEREIRA M, Jacome C, Barral-Fernandez M, Guerra-Fandino V, et al
   Safety and Efficacy of Nordic Walking Training in Adult Patients with Asthma: A Pilot Randomised Controlled Trial with a Mixed-Methods Approach.
   Respir Med. 2026 Apr 7:108817. doi: 10.1016/j.rmed.2026.108817.
   PubMed     Abstract available
   
   
   
10. SINGH D, Mancini L, Melis G, Cortellini M, et al
    Safety and tolerability of the low global warming potential propellant HFA-152a in patients with asthma receiving beclometasone dipropionate/formoterol fumarate/glycopyrronium: The TRECOS study.
    Respir Med. 2026 Apr 6:108814. doi: 10.1016/j.rmed.2026.108814.
    PubMed     Abstract available
    
    
    
11. CALZETTA L, Cazzola M, Pistocchini E, Gholamalishahi S, et al
    Exploring AI and ML in managing overlap between cardiovascular disease and asthma or COPD: a scoping review.
    Respir Med. 2026 Apr 4:108812. doi: 10.1016/j.rmed.2026.108812.
    PubMed     Abstract available
    
    
    March 2026
12. SANTOS A, Silva L
    Development and short-term effectiveness of a theory-informed, nurse-led structured rehabilitation consultation in primary care asthma management.
    Respir Med. 2026;256:108797.
    PubMed     Abstract available
    
    
    
13. RODRIGUES J, Jesus B, Caseiro P, Rama L, et al
    Body position and immersion associate with lung function differently in healthy and asthmatic endurance athletes.
    Respir Med. 2026;256:108783.
    PubMed     Abstract available
    
    
    
14. ZHANG M, Liu H, Cao W, Fan L, et al
    Causal Associations Between Chronic Obstructive Pulmonary Disease, Pulmonary Tuberculosis, Asthma, and Plasma Metabolites: A Bidirectional Mendelian Randomization Study.
    Respir Med. 2026 Mar 24:108785. doi: 10.1016/j.rmed.2026.108785.
    PubMed     Abstract available
    
    
    
15. GREIG R, Suter P, Chan R, Lipworth B, et al
    Oscillometry defined small airways dysfunction in patients with severe uncontrolled asthma and preserved spirometry.
    Respir Med. 2026 Mar 24:108790. doi: 10.1016/j.rmed.2026.108790.
    PubMed     Abstract available
    
    
    
16. KASHANI M, Rostami M, Karimi Darabi M, Jamshidi F, et al
    Explainable artificial intelligence for predicting length of stay and treatment response in pediatric asthma and allergic rhinitis: An irregular fuzzy cellular automata approach across pre- and during-COVID-19 periods.
    Respir Med. 2026;256:108784.
    PubMed     Abstract available
    
    
    
17. DASGUPTA S, Ghosh N, Bhattacharya A, Mitra I, et al
    Lipid biomarkers for differentiating asthma-COPD overlap: Insights from LC-MS-based lipidomics.
    Respir Med. 2026;255:108779.
    PubMed     Abstract available
    
    
    
18. MALIK T, Ong SC, Ibrahim BB, Ng CK, et al
    The effect of the CareAide(R) mobile application in adult outpatients with asthma: A randomised controlled trial.
    Respir Med. 2026;255:108751.
    PubMed     Abstract available
    
    
    
19. PUTERA AM, Endaryanto A, Irwanto, Sari IL, et al
    Subcutaneous immunotherapy with house dust mite extract in Indonesian children with allergic rhinitis and asthma: A double-blind randomized controlled trial.
    Respir Med. 2026;254:108753.
    PubMed     Abstract available
    
    
    
20. DE S
    Respiratory reactance index across severities of airflow obstruction in COPD and asthma.
    Respir Med. 2026;254:108752.
    PubMed    
    
    
    
21. MEULMEESTER FL, van den Akker-Van Marle ME, Ten Have L, Lanario JW, et al
    Mapping EQ-5D-5L utility scores from the severe asthma questionnaire in the SHARP CRC registry.
    Respir Med. 2026;255:108749.
    PubMed     Abstract available
    
    
    
22. LOMMATZSCH M, Schmidt O, Timmermann H, Gappa M, et al
    Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study.
    Respir Med. 2026 Mar 3:108750. doi: 10.1016/j.rmed.2026.108750.
    PubMed     Abstract available
    
    
    
23. LIN L, Zhu F, Xiao J, Yang L, et al
    The minimal clinically important difference of patient-reported outcome measures in adults with asthma: a systematic review.
    Respir Med. 2026 Mar 1:108747. doi: 10.1016/j.rmed.2026.108747.
    PubMed     Abstract available
    
    
    February 2026
24. XING Y, Li Y, Yang J, Yang J, et al
    Mapping the global landscape of biologics in allergic diseases: A bibliometric analysis.
    Respir Med. 2026;254:108734.
    PubMed     Abstract available
    
    
    
25. KANABAR SS, Pavord ID, Hinks TSC
    Treatable traits and treatment options in asthma.
    Respir Med. 2026 Feb 26:108736. doi: 10.1016/j.rmed.2026.108736.
    PubMed     Abstract available
    
    
    
26. DA SILVA CRV, Costa EC, Sarinho E, Correia Junior MGA, et al
    Anxiety is associated with asthma severity in adolescents: a school-based epidemiological study.
    Respir Med. 2026 Feb 25:108731. doi: 10.1016/j.rmed.2026.108731.
    PubMed     Abstract available
    
    
    
27. TANAKA Y, Okamura K, Kaburaki S, Tanaka T, et al
    Utility of MostGraph in Asthma Management: Comparative Study with Cough-Variant Asthma.
    Respir Med. 2026 Feb 24:108728. doi: 10.1016/j.rmed.2026.108728.
    PubMed     Abstract available
    
    
    
28. AL-IEDE M, Al-Zayadneh E, Fallouh J, Al-Huneidy R, et al
    Temporal trends and projections of asthma in North Africa and Middle East: insights from Global Burden of Disease 2023.
    Respir Med. 2026 Feb 23:108727. doi: 10.1016/j.rmed.2026.108727.
    PubMed     Abstract available
    
    
    
29. SUMINO K, D'Souza A, Tapp H, Francisco B, et al
    Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices.
    Respir Med. 2026;254:108717.
    PubMed     Abstract available
    
    
    
30. KAPATAIS C, Papaioannou AI, Fouka E, Samitas K, et al
    Optimizing adherence to inhaled therapy in asthma: Behavioral and digital strategies with insights from the Greek healthcare context.
    Respir Med. 2026 Feb 10:108709. doi: 10.1016/j.rmed.2026.108709.
    PubMed     Abstract available
    
    
    
31. LUO W, Yu Z, Zhang Y, Lin D, et al
    The C-Reactive Protein-Albumin-Lymphocyte (CALLY) index and all-cause mortality in adults with Asthma: A cohort study using NHANES 1999-2010.
    Respir Med. 2026;253:108706.
    PubMed     Abstract available
    
    
    
32. PEDROSO A, Oliveira JM, Clark VL, McLoughlin RF, et al
    Obesity and impaired muscle function in severe asthma: a cross sectional study.
    Respir Med. 2026 Feb 4:108698. doi: 10.1016/j.rmed.2026.108698.
    PubMed     Abstract available
    
    
    
33. CRISTOPOULOU ME, Panteli LS, Moisidis JAlpha, Christopoulos I IA, et al
    The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study.
    Respir Med. 2026 Feb 4:108695. doi: 10.1016/j.rmed.2026.108695.
    PubMed     Abstract available
    
    
    
34. KAZDA L, Schlub TE, Guppy M, Forrester M, et al
    Impact of carbon footprint information on inhaler prescribing intentions by general practitioners: protocol for an online factorial randomised experiment.
    Respir Med. 2026;252:108657.
    PubMed     Abstract available
    
    
    January 2026
35. JESENAK M, Diamant Z, Conti D, Antolin-Amerigo D, et al
    Corrigendum to "The EUFOREA pocket guide on paediatric asthma: A step forward in patient care" [Respir. Med. (2025) 108631].
    Respir Med. 2026 Jan 31:108692. doi: 10.1016/j.rmed.2026.108692.
    PubMed    
    
    
    
36. CUNILL V, Andreu V, Iglesias A, Berman M, et al
    Profiles of circulating T follicular helper (cTfh) cell subpopulations in patients with asthma, COPD and asthma-COPD overlap (ACO).
    Respir Med. 2026;253:108672.
    PubMed     Abstract available
    
    
    
37. MANISCALCO M, Candia C, Ambrosino P, Matera MG, et al
    Fractional Exhaled Nitric Oxide in Monitoring Biological Treatment for Severe Asthma in Adults: Clinical Implications and Future Perspectives.
    Respir Med. 2026 Jan 12:108647. doi: 10.1016/j.rmed.2026.108647.
    PubMed     Abstract available
    
    
    
38. JESENAK M, Diamant Z, Conti D, Antolin-Amerigo D, et al
    The EUFOREA pocket guide on paediatric asthma: A step forward in patient care.
    Respir Med. 2026 Jan 6:108631. doi: 10.1016/j.rmed.2025.108631.
    PubMed    
    
    
    
39. JANSON C, Malinovschi A, Borres M, Faner R, et al
    Allergic sensitization in asthma and COPD in the NOVELTY study.
    Respir Med. 2026;251:108605.
    PubMed     Abstract available
    
    
    
40. DOMAGALA-MANCZYK I, Miszczuk-Ciesla M, Maskey-Warzechowska M, Zielecki M, et al
    Limitation of the effectiveness of inhalation training in patients with asthma and COPD.
    Respir Med. 2026;251:108603.
    PubMed     Abstract available
    
    
    
41. MORIKAWA Y, Morimoto K, Kodani T, Miyahara Y, et al
    Safety and efficacy of a helium-oxygen mix for pediatric respiratory failure associated with anatomical and functional stenotic lesions of the airway: a phase II clinical trial.
    Respir Med. 2026;251:108592.
    PubMed     Abstract available
    
    
    December 2025
42. CHEN F, Lu M, Ye J, Zhang L, et al
    Association between fractional exhaled nitric oxide (FeNO) and blood eosinophil count among children and adolescents with asthma in the United States: a population-based study.
    Respir Med. 2025 Dec 31:108630. doi: 10.1016/j.rmed.2025.108630.
    PubMed     Abstract available
    
    
    
43. CLARK VL, de Oliveira JM, Gibson PG, McDonald VM, et al
    Prevalence and overlap of treatable traits in severe asthma and COPD: A cross-disease comparison in a tertiary care setting.
    Respir Med. 2025;252:108604.
    PubMed     Abstract available
    
    
    
44. JESENAK M, Bobcakova A, Golebski K, Krohn IK, et al
    Airway epithelial barrier integrity: an emerging treatable trait in asthma management.
    Respir Med. 2025;252:108579.
    PubMed     Abstract available
    
    
    
45. SUBOCZ J, Stoup T, Giovannelli J, Bourdin A, et al
    Evolution and factors associated with presenteeism in severe asthma after treatment with biologics.
    Respir Med. 2025;251:108587.
    PubMed     Abstract available
    
    
    
46. SARAVANAKUMAR T, Mohanakrishnan R
    Effects of neuromuscular breathing exercise with yogic practices on cardiopulmonary variables among women asthmatic patients: A randomized controlled trial.
    Respir Med. 2025;251:108583.
    PubMed     Abstract available
    
    
    
47. DE SANTANA MBR, Cruz AA, de Araujo JLF, Tugores RM, et al
    Variants in the Glucocorticoid Receptor gene (NR3C1), asthma control and serum cytokine levels.
    Respir Med. 2025;251:108553.
    PubMed     Abstract available
    
    
    
48. HAMZA YOUSEF MS, Al Azizi HM, Fouad MM
    Point of care ultrasound as a bedside diagnostic tool in acute dyspnea patients in emergency department for timely management.
    Respir Med. 2025;250:108500.
    PubMed     Abstract available
    
    
    November 2025
49. WANG W, Cai H, Fan H, Duan D, et al
    Occurrence of allergic bronchopulmonary aspergillosis in Chinese adults with asthma and COPD comorbidity.
    Respir Med. 2025;251:108547.
    PubMed     Abstract available
    
    
    
50. SAGAYARAJ MJ, Panneerselvam S, Jeganathan HR, Theivendren P, et al
    Advances in Asthma-COPD Overlap Treatment: A Comprehensive Review of Therapeutic Approaches.
    Respir Med. 2025 Nov 26:108542. doi: 10.1016/j.rmed.2025.108542.
    PubMed     Abstract available
    
    
    
51. CHOI YM, Womble JT, Greene ST, Vanetta C, et al
    Short-term impact of bariatric surgery on systemic inflammation in patients with asthma.
    Respir Med. 2025;250:108540.
    PubMed     Abstract available
    
    
    
52. STRIDSMAN C, Konradsen JR, Andersson N, Vanfleteren LEGW, et al
    Extremely-to-very preterm birth and being small for gestational age increase the risk of severe airflow obstruction in patients with asthma.
    Respir Med. 2025;250:108536.
    PubMed     Abstract available
    
    
    
53. ZHAO L, Chen G, Huang C, Kong W, et al
    Machine learning for prediction of eosinophilic asthma using clinical indicators as an alternative to induced sputum.
    Respir Med. 2025 Nov 19:108528. doi: 10.1016/j.rmed.2025.108528.
    PubMed     Abstract available
    
    
    
54. CHEN F, Ye J, Zhang L, Lin BQ, et al
    Associations of serum cotinine with asthma risk in US children: a mediation analysis of body mass index.
    Respir Med. 2025 Nov 12:108502. doi: 10.1016/j.rmed.2025.108502.
    PubMed     Abstract available
    
    
    
55. BARRY LE, Habib M, Heaney LG, Nianogo RA, et al
    Socioeconomic Disparities in Inpatient Outcomes Among US Pediatric Asthma Hospitalizations.
    Respir Med. 2025 Nov 11:108501. doi: 10.1016/j.rmed.2025.108501.
    PubMed     Abstract available
    
    
    
56. CHEN L, Chen H, Chen Z, Zhang K, et al
    Visceral obesity, partly mediated by a reduction in HDL-C, increases the risk of asthma: Insights from NHANES and Mendelian randomization studies.
    Respir Med. 2025;249:108482.
    PubMed     Abstract available
    
    
    
57. BERTHON BS, Williams LM, McLoughlin RF, Nichol KS, et al
    Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
    Respir Med. 2025 Nov 3:108474. doi: 10.1016/j.rmed.2025.108474.
    PubMed     Abstract available
    
    
    
58. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    PubMed     Abstract available
    
    
    
59. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    PubMed     Abstract available
    
    
    
60. AGUSTI A, Gibson P, Cazzola M
    Treatable Traits. Why, What, How?
    Respir Med. 2025;249:108421.
    PubMed     Abstract available
    
    
    October 2025
61. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    PubMed     Abstract available
    
    
    
62. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
    Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
    Respir Med. 2025;249:108444.
    PubMed     Abstract available
    
    
    
63. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    PubMed     Abstract available
    
    
    
64. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    PubMed     Abstract available
    
    
    
65. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    PubMed     Abstract available
    
    
    
66. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed     Abstract available
    
    
    September 2025
67. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    PubMed     Abstract available
    
    
    
68. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    PubMed     Abstract available
    
    
    
69. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    PubMed     Abstract available
    
    
    
70. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed     Abstract available
    
    
    August 2025
71. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed     Abstract available
    
    
    
72. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    PubMed     Abstract available
    
    
    
73. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    PubMed     Abstract available
    
    
    
74. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    PubMed     Abstract available
    
    
    
75. CHAN R, Cottini M, Menzella F, Poto R, et al
    Body mass index and lung function decline in persistent asthma.
    Respir Med. 2025 Aug 11:108304. doi: 10.1016/j.rmed.2025.108304.
    PubMed    
    
    
    
76. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    PubMed     Abstract available
    
    
    
77. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    PubMed     Abstract available
    
    
    
78. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    PubMed     Abstract available
    
    
    
79. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    PubMed     Abstract available
    
    
    July 2025
80. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    PubMed     Abstract available
    
    
    
81. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    PubMed     Abstract available
    
    
    
82. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    PubMed     Abstract available
    
    
    
83. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    PubMed     Abstract available
    
    
    
84. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    PubMed    
    
    
    
85. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    PubMed     Abstract available
    
    
    
86. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    PubMed     Abstract available
    
    
    
87. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    PubMed     Abstract available
    
    
    
88. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    PubMed     Abstract available
    
    
    June 2025
89. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    PubMed     Abstract available
    
    
    
90. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    PubMed     Abstract available
    
    
    
91. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    PubMed     Abstract available
    
    
    
92. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    PubMed     Abstract available
    
    
    
93. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    PubMed     Abstract available
    
    
    
94. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    PubMed     Abstract available
    
    
    
95. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    PubMed     Abstract available
    
    
    
96. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    PubMed     Abstract available
    
    
    
97. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    PubMed     Abstract available
    
    
    May 2025
98. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
    Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
    Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
    PubMed     Abstract available
    
    
    
99. ZHANG X, Zhang X, Wan Y, Xu D, et al
    The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
    Respir Med. 2025;245:108174.
    PubMed     Abstract available
    
    
    
100. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
     Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
     Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
     PubMed     Abstract available
     
     
     
101. XIANG J, Cui M
     Neutrophil Extracellular Traps and neutrophilic asthma.
     Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
     PubMed     Abstract available
     
     
     
102. LEMACON C, Lopes AA
     Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
     Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
     PubMed     Abstract available
     
     
     
103. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
     High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
     Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
     PubMed     Abstract available
     
     
     
104. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
     Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
     Respir Med. 2025;243:108139.
     PubMed     Abstract available
     
     
     
105. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
     Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
     Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
     PubMed     Abstract available
     
     
     April 2025
106. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
     The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
     Respir Med. 2025;243:108125.
     PubMed     Abstract available
     
     
     
107. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
     Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
     Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
     PubMed     Abstract available
     
     
     
108. GHERASIM A, Dietsch F, Odul F, Riff T, et al
     Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
     Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
     PubMed     Abstract available
     
     
     
109. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
     Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
     Respir Med. 2025;242:108096.
     PubMed     Abstract available
     
     
     
110. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
     Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
     Respir Med. 2025;240:108044.
     PubMed     Abstract available
     
     
     
111. ZHANG S, Lin J
     Association of circadian syndrome and lung health: A population-based cohort study.
     Respir Med. 2025;240:108031.
     PubMed     Abstract available
     
     
     March 2025
112. STATEN T, Liu PH, Holt C, Alismail A, et al
     Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
     Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
     PubMed     Abstract available
     
     
     
113. GREIG R, Chan R, Lipworth B
     Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab.
     Respir Med. 2025;241:108072.
     PubMed    
     
     
     
114. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
     A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
     Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
     PubMed     Abstract available
     
     
     
115. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
     Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
     Respir Med. 2025;240:108041.
     PubMed     Abstract available
     
     
     
116. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
     Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
     Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
     PubMed     Abstract available
     
     
     
117. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
     Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
     Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
     PubMed     Abstract available
     
     
     
118. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
     Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
     Respir Med. 2025;240:108032.
     PubMed     Abstract available
     
     
     
119. ZHAO C, Wang L, Zhang L, Wang Q, et al
     Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
     Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
     PubMed     Abstract available
     
     
     
120. OTTESEN TG, Rovsing AH, Ulrik CS
     Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
     Respir Med. 2025;238:107962.
     PubMed     Abstract available
     
     
     February 2025
121. SUN C, Li N, Xiao X, Zhang Q, et al
     Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
     Respir Med. 2025;240:108017.
     PubMed     Abstract available
     
     
     
122. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
     Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
     Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
     PubMed     Abstract available
     
     
     
123. JIANG P, Lu H, Jiang Y, Li F, et al
     Association between the triglyceride-glucose index and mortality in the asthma population.
     Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
     PubMed     Abstract available
     
     
     
124. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
     The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
     Respir Med. 2025;237:107940.
     PubMed     Abstract available
     
     
     January 2025
125. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
     Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
     Respir Med. 2025;238:107979.
     PubMed     Abstract available
     
     
     
126. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
     COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
     Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
     PubMed     Abstract available
     
     
     
127. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
     Challenges in treating patients with comorbid asthma and bronchiectasis.
     Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
     PubMed     Abstract available
     
     
     
128. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
     Background therapy in severe asthma on monoclonal antibody treatment in real life.
     Respir Med. 2025;237:107944.
     PubMed     Abstract available
     
     
     December 2024
129. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
     In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
     Respir Med. 2024;236:107917.
     PubMed     Abstract available
     
     
     
130. AJAZ M, Singh I, Vugic L, Jani R, et al
     The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
     Respir Med. 2024;236:107918.
     PubMed     Abstract available
     
     
     
131. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
     Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
     Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
     PubMed     Abstract available
     
     
     
132. PETAT H, Marguet C
     Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
     Respir Med. 2024;235:107875.
     PubMed     Abstract available
     
     
     November 2024
133. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
     Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
     Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
     PubMed     Abstract available
     
     
     
134. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
     End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
     Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
     PubMed     Abstract available
     
     
     
135. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
     Factors associated with uncontrolled severe asthma in the biologic era.
     Respir Med. 2024;236:107881.
     PubMed     Abstract available
     
     
     
136. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
     Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
     Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
     PubMed     Abstract available
     
     
     
137. SESHADRI N, Faig W, Young LR, Hill DA, et al
     Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
     Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
     PubMed     Abstract available
     
     
     
138. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
     Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
     Respir Med. 2024;234:107853.
     PubMed     Abstract available
     
     
     
139. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
     Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
     Respir Med. 2024;233:107779.
     PubMed     Abstract available
     
     
     October 2024
140. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
     beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
     Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
     PubMed     Abstract available
     
     
     
141. ZHENG K, Tang L, Wang X, Chen L, et al
     The risk factors for chronic cough in children: A meta-analysis covering five continents.
     Respir Med. 2024;232:107752.
     PubMed     Abstract available
     
     
     
142. WU WW
     Association of naples prognostic score and lung health: A population-based study.
     Respir Med. 2024;232:107751.
     PubMed     Abstract available
     
     
     September 2024
143. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
     High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
     Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
     PubMed     Abstract available
     
     
     
144. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
     Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
     Respir Med. 2024;234:107808.
     PubMed     Abstract available
     
     
     
145. NOPSOPON T, Brown A, Hahn G, Rank M, et al
     Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
     Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
     PubMed     Abstract available
     
     
     
146. QUEZADA WA, Angulo D, Murray S, Joo M, et al
     Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
     Respir Med. 2024;231:107695.
     PubMed     Abstract available
     
     
     August 2024
147. WHARTON R, Mathis N, Wang JG, Meislin R, et al
     Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
     Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
     PubMed    
     
     
     
148. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
     Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
     Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
     PubMed     Abstract available
     
     
     
149. NORWEG A, Oh C, Nolan A
     Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
     Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
     PubMed    
     
     
     
150. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
     Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
     Respir Med. 2024;230:107693.
     PubMed     Abstract available
     
     
     July 2024
151. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
     Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
     Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
     PubMed     Abstract available
     
     
     
152. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
     The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
     Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
     PubMed     Abstract available
     
     
     
153. SORIANO JB, Polverino F
     Sexual activity and respiratory disease: A systematic review.
     Respir Med. 2024;228:107665.
     PubMed     Abstract available
     
     
     June 2024
154. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
     Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
     Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
     PubMed     Abstract available
     
     
     
155. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
     Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
     Respir Med. 2024;231:107714.
     PubMed     Abstract available
     
     
     
156. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
     A soft systems approach of asthma management in children based on therapeutic education and e-learning.
     Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
     PubMed     Abstract available
     
     
     
157. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
     Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
     Respir Med. 2024;227:107638.
     PubMed     Abstract available
     
     
     May 2024
158. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
     Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
     Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
     PubMed     Abstract available
     
     
     
159. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
     The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
     Respir Med. 2024;226:107609.
     PubMed    
     
     
     April 2024
160. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
     Are biologics effective on lung hyperinflation in patients with resistant asthma?
     Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
     PubMed    
     
     
     
161. CAZZOLA M, Maniscalco M
     Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
     Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
     PubMed    
     
     
     
162. JI H, Tan LD, Hafzella G, Nguyen N, et al
     Navigating Biologic Therapies in Elderly Asthma.
     Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
     PubMed     Abstract available
     
     
     
163. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
     Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
     Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
     PubMed     Abstract available
     
     
     
164. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
     Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
     Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
     PubMed     Abstract available
     
     
     
165. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
     Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
     Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
     PubMed     Abstract available
     
     
     
166. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
     The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
     Respir Med. 2024;224:107564.
     PubMed     Abstract available
     
     
     
167. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
     Predicting exacerbations in COPD in the Danish general population.
     Respir Med. 2024;224:107557.
     PubMed     Abstract available
     
     
     
168. LAI K, Sun D, Dai R, Samoro R, et al
     Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
     Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
     PubMed     Abstract available
     
     
     
169. XU X, Yin J, Yang Y, Liu H, et al
     Advances in co-pathogenesis of the united airway diseases.
     Respir Med. 2024;225:107580.
     PubMed     Abstract available
     
     
     March 2024
170. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
     A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
     Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
     PubMed     Abstract available
     
     
     
171. JEONG J, Nam YH, Sim DW, Kim BK, et al
     Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
     Respir Med. 2024;225:107598.
     PubMed     Abstract available
     
     
     
172. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
     Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
     Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
     PubMed     Abstract available
     
     
     February 2024
173. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
     Impact of biologics on lung hyperinflation in patients with severe asthma.
     Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
     PubMed     Abstract available
     
     
     
174. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
     No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
     Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
     PubMed     Abstract available
     
     
     November 2023
175. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
     A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
     Respir Med. 2023;219:107435.
     PubMed     Abstract available
     
     
     October 2023
176. KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
     Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
     Respir Med. 2023;217:107334.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum